The global interventional cardiology and peripheral vascular devices market size reached US$ 25.0 Billion in 2023. Looking forward, the market is projected to reach US$ 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.27% during 2023-2032. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts.
These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes.
Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts.
These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
Interventional Cardiology and Peripheral Vascular Devices Market Trends
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery.In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes.
Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
Key Market Segmentation
This report provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2024-2032. The report has categorized the market based on product type, indication, age group, and end user.Product Type Insights:
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Accessories
- Angioplasty Balloons
- Angioplasty Stents
- Angioplasty Catheters
- Endovascular Aneurysm Repair Stent Grafts
Indication Insights:
- Coronary Intervention
- Peripheral Arterial Disease
Age Group Insights:
- Geriatric
- Adults
- Paediatric
End User Insights:
- Hospitals
- Ambulatory Surgical Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report
- How has the global interventional cardiology and peripheral vascular devices market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global interventional cardiology and peripheral vascular devices market?
- What is the impact of each driver, restraint, and opportunity on the global interventional cardiology and peripheral vascular devices market?
- What are the key regional markets?
- Which countries represent the most attractive interventional cardiology and peripheral vascular devices market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the interventional cardiology and peripheral vascular devices market?
- What is the breakup of the market based on the indication?
- Which is the most attractive indication in the interventional cardiology and peripheral vascular devices market?
- What is the breakup of the market based on the age group?
- Which is the most attractive age group in the interventional cardiology and peripheral vascular devices market?
- What is the breakup of the market based on end user?
- Which is the most attractive end user in the interventional cardiology and peripheral vascular devices market?
- What is the competitive structure of the global interventional cardiology and peripheral vascular devices market?
- Who are the key players/companies in the global interventional cardiology and peripheral vascular devices market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Interventional Cardiology and Peripheral Vascular Devices Market
6 Market Breakup by Product Type
7 Market Breakup by Indication
8 Market Breakup by Age Group
9 Market Breakup by End User
10 Market Breakup by Region
11 Drivers, Restraints, and Opportunities
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cook Group Incorporated
- Cordis Corporation
- Koninklijke Philips N.V.
- Medtronic plc.
- Teleflex Incorporated
- Terumo Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 136 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 25 Billion |
| Forecasted Market Value ( USD | $ 47 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
